Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: A meta-analysis

Gene

Volumn 528, Issue 2, 2013, Pages 335-342

  Dai, Qiang Sheng ^a   Hua, Rui Xi ^a   Zhang, Ruoxin ^b   Huang, Yu Shan ^c   Hua, Zhu Ming ^d   Yun, Cheang Tuck ^e   Zeng, Rui Fang ^a   Long, Jian Ting ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Guangzhou Kingmed Center for Clinical Laboratory   (China)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e SUN YAT SEN UNIVERSITY   (China)

Author keywords

Meta analysis; PAT; Polymorphism; Susceptibility; XPC

Indexed keywords

XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; DNA POLYMORPHISM; ESOPHAGUS CANCER; ETHNICITY; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HETEROZYGOTE; HUMAN; LUNG CANCER; META ANALYSIS (TOPIC); MOUTH CANCER; NASOPHARYNX CANCER; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECESSIVE GENE; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; STOMACH CANCER; UROGENITAL TRACT CANCER;

CBM; CHINESE BIOMEDICAL; CI; CONFIDENCE INTERVAL; DNA REPAIR CAPACITY; DRC; HARDY-WEINBERG EQUILIBRIUM; HWE; META-ANALYSIS; NER; NUCLEOTIDE EXCISION REPAIR; ODDS RATIO; OR; PAT; PAT -/+; POLY (AT) DELETION/INSERTION; POLYMORPHISM; SCCNH; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK; SUSCEPTIBILITY; XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP C; XPC;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 84883054511     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.06.092     Document Type: Article

References (59)

1. Andrew A.S., et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006, 27:1030-1037.
2. Blankenburg S., et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005, 26:1085-1090.
3. Casson A.G., Zheng Z., Evans S.C., Veugelers P.J., Porter G.A., Guernsey D.L. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005, 26:1536-1541.
4. Dai Q., Yang Z.H., Ye Y.L. [Association between XPC gene polymorphisms and nasopharyngeal cancer risk]. Chin. J. Gerontol. 2007, 27:1671-1673.
5. De Ruyck K., et al. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res. 2007, 631:101-110.
6. de Verdier P.J., Sanyal S., Bermejo J.L., Steineck G., Hemminki K., Kumar R. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat. Res. 2010, 694:39-44.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
8. Dong Z., et al. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in North China. J. Clin. Gastroenterol. 2008, 42:910-915.
9. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
10. Francisco G., Menezes P.R., Eluf-Neto J., Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur. J. Hum. Genet. 2008, 16:724-734.
11. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 2001, 1:22-33.
12. Gangwar R., Mandhani A., Mittal R.D. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. J. Cancer Res. Clin. Oncol. 2010, 136:779-786.
13. Gao J., et al. Relationship between polymorphisms of DNA repair genes and glutathione-S-transferase genes and risk of biliary tract cancer. Tumor 2009, 29:145-151.
14. Goncalves F.T., et al. European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil. J. Dermatol. Sci. 2011, 64:59-66.
15. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
16. Guo W., et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North China. J. Cancer Res. Clin. Oncol. 2008, 134:263-270.
17. He J., Shi T.Y., Zhu M.L., Wang M.Y., Li Q.X., Wei Q.Y. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis. Int. J. Cancer 2013, 10.1002/ijc.28089.
18. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
19. Huang S., Yi B., Hu J.B. XPC-PAT polymorphism and genetic predisposition to colorectal cancer. Beijing Med. 2009, 31:663-665.
20. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
21. Khan S.G., et al. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis 2000, 21:1821-1825.
22. Khan S.G., et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res. 2002, 30:3624-3631.
23. Kietthubthew S., Sriplung H., Au W.W., Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int. J. Hyg. Environ. Health 2006, 209:21-29.
24. Lee G.Y., et al. XPC polymorphisms and lung cancer risk. Int. J. Cancer 2005, 115:807-813.
25. Liu J.W., Lei W., Yang X.M., Xue R.G. Association between DNA repair gene XPC poly (AT) polymorphism and esophageal cancer genetics susceptibility. Hebei Med. 2006, 12:1159-1160.
26. Liu Y., et al. Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population. Cancer Genet. 2012, 205:205-211.
27. Liu Y., et al. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk. Oncol. Rep. 2012, 28:337-345.
28. Lopez-Cima M.F., et al. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 2007, 7:162.
29. Mandal R.K., Gangwar R., Kapoor R., Mittal R.D. Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population. Indian J. Med. Res. 2012, 135:64-71.
30. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
31. Marin M.S., Lopez-Cima M.F., Garcia-Castro L., Pascual T., Marron M.G., Tardon A. Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1788-1793.
32. Mittal R.D., Mandal R.K. Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Ind. J. Hum. Genet. 2012, 18:47-55.
33. Nelson H.H., Christensen B., Karagas M.R. The XPC poly-AT polymorphism in non-melanoma skin cancer. Cancer Lett. 2005, 222:205-209.
34. Palli D., et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis 2010, 25:569-575.
35. Pan J., et al. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009, 30:785-792.
36. Qiao Y., et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res. 2002, 509:165-174.
37. Qiao Y., et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002, 23:295-299.
38. Qiu L., Wang Z., Shi X. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur. J. Cancer 2008, 44:2241-2253.
39. Sak S.C., Barrett J.H., Paul A.B., Bishop D.T., Kiltie A.E. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br. J. Cancer 2005, 92:2262-2265.
40. Saldivar J.S., et al. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients. Gynecol. Oncol. 2007, 107:S223-S229.
41. Shen H., et al. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res. 2001, 61:3321-3325.
42. Shore R.E., et al. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int. J. Cancer 2008, 122:2101-2105.
43. Sugasawa K., et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell 1998, 2:223-232.
44. Sugimura T., et al. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J. Oral Pathol. Med. 2006, 35:11-18.
45. Thoma B.S., Vasquez K.M. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol. Carcinog. 2003, 38:1-13.
46. van Houwelingen H.C., Arends L.R., Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat. Med. 2002, 21:589-624.
47. Wang Y.G., Xing D.Y., Tan W., Wang L.J., Tang P.Z., Lin D.X. Poly(AT) polymorphism in DNA repair gene XPC and lung cancer risk. Zhonghua Zhong Liu Za Zhi 2003, 25:555-557.
48. Wang L., Lin D.X., Lu X.H., Miao X.P., Li H. Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk. Wei Sheng Yan Jiu 2006, 35:534-536.
49. Wood R.D. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 1999, 81:39-44.
50. Wu X., et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet. 2006, 78:464-479.
51. Wu Y., et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol. Carcinog. 2011, 50:189-198.
52. Xi J., Kang S., Sun D.W., Zhang M., Zhang F.X. Association between XPC gene polymorphisms and ovarian carcinoma risk. Chin. J. Pract. Gynecol. Obstet. 2008, 24:688-690.
53. Yang M., et al. Associations between XPC expression, genotype, and the risk of head and neck cancer. Environ. Mol. Mutagen. 2005, 45:374-379.
54. Yang Z.H., Liang W.B., Jia J., Wei Y.S., Zhou B., Zhang L. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma. Acta Oncol. 2008, 47:379-384.
55. Yuan P., et al. Polymorphisms in nucleotide excision repair genes XPC and XPD and clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer. Zhonghua Yi Xue Za Zhi 2005, 85:972-975.
56. Yuan P., et al. Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy. Ai Zheng 2005, 24:1510-1513.
57. Zhang D., et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J. Hum. Genet. 2008, 53:18-33.
58. Zhou R.M., Wang N., Guo W. Correlation of polymorphisms in xeroderma pigmentosum group C to the risk of ovarian carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29:91-92.
59. Zhu Y., et al. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 2007, 28:698-703.